2019
DOI: 10.1111/and.13463
|View full text |Cite
|
Sign up to set email alerts
|

Asthenozoospermia: Cellular and molecular contributing factors and treatment strategies

Abstract: | INTRODUC TI ONIn recent years, many researchers have focused on possible factors leading to male infertility and revealed the existence of many cellular and molecular defects during sperm production and maturation. These defects finally affect the count and structure of spermatozoa and reduce the ability of spermatozoa to reach and fertilise the egg. A decrease in sperm motility, called "asthenozoospermia," is one of these important deficiencies, which is influenced by various cellular and molecular factors.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
66
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 85 publications
(66 citation statements)
references
References 89 publications
0
66
0
Order By: Relevance
“…Moreover, the exclusion criteria included any acute illness during the study, admission of less than 90% of the supplement, leaving the study based on the personal desire of the participants, attendance at another research study, immigration, and unavailability for follow-up. Additionally, those men with varicocele [ 36 ], epididymo-orchitis [ 37 ], sexually transmitted diseases [ 38 ], and systemic diseases [ 39 ] were excluded based on the proved negative effects of the above-mentioned pathologies on male fertility and sperm motility [ 40 ]. Furthermore, men with endocrinopathies such as hyperthyroidism and hypothyroidism were excluded as well, because hyperthyroidism is associated with the reduced semen volume and reduced sperm density, motility, and morphology, and hypothyroidism is associated with the reduced sperm morphology [ 41 , 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, the exclusion criteria included any acute illness during the study, admission of less than 90% of the supplement, leaving the study based on the personal desire of the participants, attendance at another research study, immigration, and unavailability for follow-up. Additionally, those men with varicocele [ 36 ], epididymo-orchitis [ 37 ], sexually transmitted diseases [ 38 ], and systemic diseases [ 39 ] were excluded based on the proved negative effects of the above-mentioned pathologies on male fertility and sperm motility [ 40 ]. Furthermore, men with endocrinopathies such as hyperthyroidism and hypothyroidism were excluded as well, because hyperthyroidism is associated with the reduced semen volume and reduced sperm density, motility, and morphology, and hypothyroidism is associated with the reduced sperm morphology [ 41 , 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…Fourthly, some genetic mutations might have negative effects on sperm immobility. Fifthly, lifestyle risk factors, such as smoking, alcohol consumption, chemical pesticides exposure, etc [6].…”
Section: Introductionmentioning
confidence: 99%
“…A significant proportion of male infertility cases is accompanied by abnormal semen quality including asthenospermia, teratospermia, oligozoospermia, and azoospermia [ 1 ]. However, asthenospermia, which is associated with poor sperm viability and motility, is the leading factor in male infertility [ 1 , 2 ]. Many causes of asthenospermia have been reported so far [ 3 , 4 , 5 ], which include dysplasia of fibrous sheath, defects in the action of cilium, disfunction of energy metabolism, dysplasia of calcium channel [ 3 , 4 ].…”
Section: Introductionmentioning
confidence: 99%